Skip to main content

Abciximab Injection Shortage

Last Updated: April 29, 2019
Status: Discontinued

Products Affected - Description
    • Reopro intravenous injection, Janssen, 2 mg/mL, 5 mL vial, 1 count, NDC 57894-0200-01 - discontinued
Reason for the Shortage
    • Janssen had Reopro on shortage due to a production interruption at their third party manufacturing site. Janssen is not pursuing new lots of Reopro.
    • There are no other suppliers of abciximab.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Janssen will no longer have Reopro in the US. The last lot expires September 2019.


Updated April 29, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 16, 2018 by Megan Dryer, PharmD. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.